As CD133 expression is now recognized as one of the most important biomarkers for the enrichment of stem-like tumor cells, the Ets motifs and Ras/ERK pathway we identified in this study could lead to a more comprehensive understanding of the molecular basis of tumor stemness. The gene discussed is PROM1; the disease is neoplasm.